Cloning of equine interleukin 1 receptor antagonist and determination of its full-length cDNA sequence

American Journal of Veterinary Research

Volumn 59, Issue 6, 1998, Pages 712-716

  Howard, Rick D ^a,c   McIlwraith, C Wayne ^a   Trotter, Gayle W ^a   Nyborg, Jennifer K ^b  

^a Department of Environmental and Radiological Health Sciences   (United States)

^b CO 80523jessicawitt colostateedunatetenhundfeld colostateeduzachking colostateeduhttp: amplabcolostateedu   (United States)

^c VIRGINIA MARYLAND REGIONAL COLLEGE OF VETERINARY MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; IL1RN PROTEIN, HUMAN; IL1RN PROTEIN, MOUSE; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; RECOMBINANT PROTEIN; SIALOGLYCOPROTEIN;

AMINO ACID SEQUENCE; ANIMAL; ARTICLE; BIOSYNTHESIS; CHEMISTRY; DNA PROBE; DRUG ANTAGONISM; GENE LIBRARY; HORSE; HUMAN; IMMUNOLOGY; MOLECULAR CLONING; MOLECULAR GENETICS; MONOCYTE; MOUSE; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; RABBIT; RAT; SEQUENCE ALIGNMENT; SEQUENCE HOMOLOGY;

AMINO ACID SEQUENCE; ANIMALS; BASE SEQUENCE; CLONING, MOLECULAR; DNA PROBES; DNA, COMPLEMENTARY; GENE LIBRARY; HORSES; HUMANS; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; MICE; MOLECULAR SEQUENCE DATA; MONOCYTES; POLYMERASE CHAIN REACTION; RABBITS; RATS; RECEPTORS, INTERLEUKIN-1; RECOMBINANT PROTEINS; SEQUENCE ALIGNMENT; SEQUENCE HOMOLOGY, AMINO ACID; SIALOGLYCOPROTEINS;

EID: 0032088940     PISSN: 00029645     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Dinarello CA. The role of interleukin-1 in host responses to infectious diseases. Infect Agents Dis 1992;1:227-236.
2. Dinarello CA. Interleukin-1 and interleukin-1 antagonism. Blood 1991;77:1627-1652.
3. March CJ, Mosley B, Larsen A, et al. Cloning, sequence and expression of two distinct human interleukin-1 complementary cDNA's. Nature 1985;315:641-647.
4. Dripps DJ, Brandhuber BJ, Thompson RC, et al. Interleukin-1 (IL-1) receptor antagonist binds to the 80-kDa IL-1 receptor but does not initiate IL-1 signal transduction. J Biol Chem 1991;266: 10331-10336.
5. Dinarello CA, Rossenwasser LJ, Wolff SM. Demonstration of a circulating suppressor factor of thymocyte proliferation during endotoxin fever in humans. J Immunol 1981;127:2517-2519.
6. Liao Z, Grimshaw RS, Rosenstreich DL. Identification of a specific interleukin-1 inhibitor in the urine of febrile patients. J Exp Med 1984;159:125-136.
7. Shaldon S, Koch KM, Bingel M, et al. Modulation of plasma interleukin-1 and its circulating protein inhibitor (CPI) by hemodialysis and hemofiltration. Kidney Int 1987;31:245-249.
8. Arend WP, Joslin FG, Thompson RC, et al. An IL-1 inhibitor from human monocytes. Production and characterization of biologic properties. J Immunol 1989;143:1851-1858.
9. Seckinger P, Dayer JM. Interleukin-1 inhibitors. Ann Inst Pasteur/Immunol 1987;138:456-488.
10. Mazzei GJ, Seckinger PL, Dayer JM, et al. Purification and characterization of a 26-kDa competitive inhibitor of interleukin 1. Eur J Immunol 1990;20:683-689.
11. Seckinger P, Lowenthal JW, Williamson K, et al. A urine inhibitor of interleukin-1 activity that blocks ligand binding. J Immunol 1987;139:1546-1549.
12. 2 and collagenase production by fibroblasts and synovial cells is regulated by urine-derived human interleukin 1 and inhibitor(s). J Clin Invest 1986;78:1120-1124.
13. Dayer-Metroz MD, Wollheim CB, Seckinger P, et al. A natural interleukin 1 (IL-1) inhibitor counteracts the inhibitory effects of IL-1 on insulin production in cultured rat pancreatic islets. J Autoimmun 1989;2:163-171.
14. Eisenberg SP, Evans RJ, Arend WP, et al. Primary structure and functional expression from complementary DNA of a human interleukin-1 receptor antagonist. Nature 1990;343:341-346.
15. Hannum CH, Wilcox CJ, Arend WP, et al. Interleukin-1 receptor antagonist activity of a human interleukin-1 inhibitor. Nature 1990;343:336-340.
16. Carter DB, Deibel MR, Dunn CJ, et al. Purification, cloning, expression and biological characterization of an interleukin-1 receptor antagonist protein. Nature 1990;344:633-638.
17. Matsushime H, Roussel MF, Matsushima K, et al. Cloning and expression of murine interleukin-1 receptor antagonist in macrophages stimulated by colony-stimulating factor 1. Blood 1991;78: 616-623.
18. Shuck ME, Eessalu TE, Tracey DE, et al. Cloning, heterologous expression and characteristics of murine interleukin 1 receptor antagonist protein. Eur J Immunol 1991;21:2775-2780.
19. Zahedi K, Seldin MF, Rits M, et al Mouse IL-1 receptor antagonist protein. Molecular characterization, gene mapping, and expression of mRNA in vitro and in vivo. J Immunol 1991;146:4228-4233.
20. Goto F, Goto K, Miyata T, et al. Interleukin-1 receptor antagonist in inflammatory exudate cells of rabbits. Production, purification and determination of primary structure. Immunology 1992; 77:235-244.
21. Eisenberg SP, Brewer MT, Verderber E, et al. Interleukin 1 receptor antagonist is a member of the interleukin 1 gene family: evolution of a cytokine control mechanism Proc Natl Acad Sci U S A 1991;88:5232-5236.
22. Dinarello CA, Thompson RC. Blocking IL-1: interleukin 1 receptor antagonist in vivo and in vitro. Immunol Today 1991;12: 404-410.
23. Arend WP, Welgus HG, Thompson RC, Eisenberg SP. Biological properties of recombinant human monocyte derived interleukin-1 receptor antagonist. J Clin Invest 1990;85:1694-1697.
24. Smith RJ, Justen JM, Ulrich RG, et al. Induction of neutral proteinase and prostanoid production in bovine nasal chondrocytes by interleukin-1 and tumor necrosis factor alpha: modulation of these cellular responses by interleukin 6 and platelet-derived growth factor. Clin Immunol Immunopathol 1992;64:135-144.
25. Seckinger P, Yaron I, Meyer FA, et al. Modulation of the effects of interleukin-1 on glycosaminoglycan synthesis by the urine-derived interleukin-1 inhibitor, but not by interleukin 6. Arthritis Rheum 1990;33:1807-1814.
26. Smith RJ, En Chin J, Sam LM, et al. Biologic effects of an interleukin-1 receptor antagonist protein on interleukin-1 stimulated cartilage erosion and chondrocyte responsiveness. Arthritis Rheum 1991;34:78-83.
27. Seckinger P, Klein-Nulend J, Alander C, et al. Natural and recombinant IL-1 receptor antagonists block the effects of IL-1 on bone resorption and prostaglandin production. J Immunol 1990;145: 4181-4184.
28. Granowitz EV, Clark BD, Vannier E, et al. Interleukin-1 receptor antagonist inhibits interleukin-1 induced cytokine synthesis by human monocytes. Clin Res 1991;39:462.
29. Howard RD, McIlwraith CW, Trotter GW, et al. Cloning of equine interleukin-1α and equine interleukin-1β and determination of their full-length cDNA sequences. Am J Vet Res 1998;59:xxx-xxx.
30. Saiki RK, Scharf F, Faloona, et al. Enzymatic amplification of beta-globin genomic sequences and restriction site analysis for diagnosis of sickle cell anemia. Science 1985;230:1350-1354.
31. Feinberg AP, Vogelstein B. A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity. Anal Biochem 1983;132:6-13.
32. Birnboim HC, Doly J. A rapid alkaline extraction procedure for screening recombinant plasmid DNA. Nucleic Acids Res 1979;7: 1513-1523.
33. Sanger F, Nicklen S, Coulson AR. DNA sequencing with chain termination inhibitors. Proc Natl Acad Sci U S A 1977;74: 5463-5467.
34. Seckinger P, Yaron I, Meyer FA, et al. Modulation of the effects of interleukin-1 on glycosaminoglycan synthesis by the urine-derived interleukin-1 inhibitor, but not by interleukin 6. Arthritis Rheum 1990;33:1807-1814.
35. Henderson B, Thompson RC, Hardingham T, et al. Inhibition of interleukin-1-induced synovitis and articular cartilage proteoglycan loss in the rabbit knee by recombinant human interleukin-1 receptor antagonist. Cytokine 1991;3:246-249.
36. Smith RJ, En Chin J, Sam LM, et al. Biologic effects of an interleukin-1 receptor antagonist protein on interleukin-1 stimulated cartilage erosion and chondrocyte responsiveness. Arthritis Rheum 1991;34:78-83.
37. Wooley PH, Whalen JD, Chapman DL, et al. The effect of an interleukin-1 receptor antagonist protein on type II collagen and antigen-induced arthritis in mice. Arthritis Rheum 1993;36:1305-1314.